Moderna has recently announced that it has urged the Food and Drug Administration (FDA) to approve its low-dose vaccine for children under 6 after interim results showed some efficacy against infections during the Omicron wave.
Moderna has recently announced that it has urged the Food and Drug Administration (FDA) to approve its low-dose vaccine for children under 6 after interim results showed some efficacy against infections during the Omicron wave.
Get updates delivered right to your inbox!
